Enable Injections’ $215 Million Series C Financing

Wilson Sonsini Goodrich & Rosati advised Enable Injections on the deal.Enable Injections, Inc., a company developing and manufacturing the enFuse platform of investigational wearable drug delivery…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here